Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06954480 |
| Title | Investigating Datopotamab Deruxtecan Plus Durvalumab Versus Datopotamab Deruxtecan in Patients With PDL1-negative Metastatic Triple-negative Breast Cancer (DIAMOND) |
| Acronym | DIAMOND |
| Recruitment | Recruiting |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Queen Mary University of London |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Barts Cancer Institute, Centre of Experimental Cancer Medicine | NOT_YET_RECRUITING | London | EC1M 6BQ | United Kingdom | Details | |
| Barts Health NHS Trust | RECRUITING | London | United Kingdom | Details |